炎症酶介导的失生症调节了NAFLD和肥胖的进展
Jorge Henao-Mejia1, Eran Elinav, Chengcheng Jin
1Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Nature
|February 3, 2012
概括
缺陷的NLRP3和NLRP6炎症酶通过改变肠道微生物群,增加肝炎和代谢综合征,加剧非酒精性脂肪性肝病 (NAFLD) 的进展. 这突显了肠道微生物组在NAFLD病变发生过程中的关键作用.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 微生物学 微生物学
背景情况:
- 非酒精性脂肪肝 (NAFLD) 是一个日益严重的全球健康问题,通常与代谢综合征有关.
- 从NAFLD到非酒精性脂肪肝炎 (NASH) 的进展,其特点是炎症和潜在的肝硬化,尚未完全理解.
- 人们越来越认识到肠道微生物群在代谢和炎症疾病中的作用.
研究的目的:
- 研究NLRP6和NLRP3炎症酶在NAFLD和代谢综合征的进展中的作用.
- 阐明炎症酶对肠道微生物群组成和宿主代谢产生影响的机制.
- 为了确定炎症酶缺乏对肝炎和胆固醇炎症的影响.
主要方法:
- 利用各种小鼠模型研究NAFLD和代谢综合征.
- 评估了炎症酶缺乏对肠道微生物群组成和功能的影响.
- 分析了微生物产品 (TLR4和TLR9激动剂) 流入门户循环的流入.
- 测量了TNF-α等关键炎症媒介的肝脏表达.
主要成果:
- NLRP6和NLRP3炎症体,以及IL-18,对NAFLD/NASH进展和代谢综合征进行负面调节.
- 炎症酶缺乏导致肠道微生物群的改变,加剧肝硬化和炎症.
- 在炎症酶缺乏的小鼠中,TLR4和TLR9主激素的门流量增加增强了肝脏TNF-α的表达,导致NASH.
- 共同住房实验表明,炎症酶缺乏会加剧肥胖和肝硬化症.
结论:
- 缺陷的NLRP3和NLRP6炎症酶传感改变了肠道微生物群与宿主之间的相互作用,促进了NAFLD/NASH的进展.
- 这些发现强调了肠道微生物群在代谢综合征和相关肝病的发病过程中的关键作用.
- 这项研究强调了系统性自身炎症途径和通过肠道微生物群的代谢障碍之间的潜在联系.
相关概念视频
01:24Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.6K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
01:26Gastritis II: Pathophysiology
52
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
52
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
34
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34
01:25Inflammatory Bowel Disease III: Crohn's Disease
35
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35
01:23Irritable Bowel Syndrome
36
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility...
36